Mitsumi Distribution spearheading Technological Advancement at GITEX Africa 2024.

DUBAI, UAE – African Media Agency – 14 May 2024 – Mitsumi Distribution, a leading IT, Telco, Value and AI distributor in the Middle East and Africa, proudly announces its participation in GITEX Africa 2024. With a widespread presence spanning 28 countries and strategic partnerships with over 27+ vendors, Mitsumi Distribution is poised to showcase front-line technological advancements and innovations at this esteemed event.

Mr. Mitesh Shah – Managing Director

Mitsumi’s focus at GITEX Africa 2024 revolves around the theme of “Pioneering Future Solutions Today.” Reflecting this commitment, Mitsumi will unveil an extensive array of pioneering technologies and innovative solutions that are reshaping the landscape of IT, Telco, AI, and value-driven solutions. In the realm of AI, Mitsumi will showcase advancements such as machine learning, generative AI, computer vision, and AI-driven chatbots, among others. In the Value Division section, emphasis will be placed on cloud solutions, security, infrastructure solutions, and more. Seasoned experts from Mitsumi, alongside key principals, will be on hand to provide insights and facilitate direct engagement with the latest industry innovations. The prestigious vendors showcased at Mitsumi’s booth are industry giants such as Acer, Array Networks, Asus, Canon, DellTechnologies, HPE, HP, Infinix, Lenovo, Lexar, Oppo, Samsung, Seagate, Techno, and VIVO.

We are thrilled to announce our participation in GITEX Africa 2024,” exclaimed Mr. Mitesh Shah, Managing Director at Mitsumi Distribution. “In this ever-evolving landscape of innovation, AI stands out as one of the most prominent topics, continually expanding its reach and impact. We are excited to seize this opportunity to unveil new partnerships and business plans, further propelling our commitment to driving technological advancement and empowering businesses across Middle East & Africa and showcasing our solutions from the top vendors”.

Visit Mitsumi Distribution at Stand 5B-20, Hall No.5, CLOUD X IOT X AI, from the 29th of May to the 31st of May 2024 to experience firsthand the advanced technologies and solutions shaping the future. Engage with Mitsumi’s team of experts, explore the latest projects and developments, and discover how Mitsumi can empower your organization to thrive in the digital age.

About Mitsumi Distribution

Mitsumi Distribution is a leading technology provider specializing in distribution channels in Africa, the Middle East and African French-speaking countries. With over two decades of experience, Mitsumi Distribution has firmly established itself as a trusted authority in the region. The company offers a wide range of innovative technology products & solutions, with a focus on IT, Telco, AI, cloud computing, networking, servers and storage. Mitsumi Distribution is committed to providing superior quality products, exceptional service and unparalleled value to its valued partners. www.mitsumidistribution.com

MedSource Labs Announces Innovation in Safety, Accuracy and Functionality of IV Catheters

MedSource Labs Unveils ClearSafe Comfort® and TrueSafe Comfort® Blood Control Safety IV Catheters to protect medical staff and patients

[Minneapolis, Minnesota, Chanhassen], May 14, 2024 (GLOBE NEWSWIRE) — MedSource Labs moves the needle in the peripheral safety IV market with the announcement of ClearSafe Comfort and TrueSafe Comfort Blood Control IV Catheters with groundbreaking active blood control check valve technology.

ClearSafe Comfort and TrueSafe Comfort Blood Control IV catheters provide significant benefits over other IV catheters.

  1. Safety: A new blood control device to significantly reduce the risk of exposure to bloodborne pathogens to the caregiver and patient.
  2. Precision: A translucent flashback chamber confirms vessel entry and ensures accuracy.
  3. Front-line functionality: The ergonomic design and non-slip grip ensure easy handling for healthcare workers.

 

“Healthcare professionals subject themselves to the risks associated with needlestick injuries and exposure to bloodborne pathogens every time they access a vein,” said Dave Kunelius, President at MedSource Labs. “ClearSafe Comfort and TrueSafe Comfort Blood Control Safety IV Catheters have been engineered to minimize these risks, allowing medical staff to better serve their patients without distraction or worry.”

These devices conform to the U.S. Needlestick Safety and Prevention Act.

MedSource Labs is a leading medical product developer and supplier specializing in high-quality products and innovative medical product development. The ClearSafe Comfort and TrueSafe Comfort Blood Control Safety IV Catheters are part of MedSource Labs’ high-performing IV catheter lines focused on caring for the caregiver. See the TrueSafe Animations and ClearSafe Animations for a detailed view.

“Quality has always been a key component of our IV catheter products, and the ClearSafe Comfort and TrueSafe Comfort blood control products raise the bar for medical staff safety and patient care,” said Kunelius.

MedSource Labs is ISO 13485:2016 certified for quality management in medical device manufacturing, registered with the FDA, and the blood control catheters are 510(k) Cleared Products.

ABOUT MEDSOURCE LABS

MedSource Labs is a leading provider of quality medical products, specializing in high-quality products, equipment and innovative class II medical product development. For over two decades, MedSource Labs has been a trusted provider of quality medical products at a superb value. Recently, MedSource Labs has expanded into new markets and grown its international services and offerings, including a focus on the EMERGE product imagine/design/build process.

Attachment

Jeremy Belloit
MedSource Labs
(952) 472-0131
jbelloit@medsourcelabs.com

GlobeNewswire Distribution ID 9116905

‫ميتسومي للتوزيع تقود التقدم التكنولوجي في معرض جيتكس أفريقيا 2024

دبي، الإمارات العربية المتحدة – 14 مايو 2024 – تعلن شركة ميتسومي للتوزيع، الشركة الرائدة في مجال توزيع تكنولوجيا المعلومات والاتصالات وعروض القيمة والذكاء الاصطناعي في الشرق الأوسط وإفريقيا، بفخر عن مشاركتها في معرض جيتكس أفريقيا 2024. ومع تواجد واسع النطاق يشمل 28 دولة فضلاً عن الشراكات الاستراتيجية مع أكثر من 27 بائعًا، تستعد شركة ميتسومي للتوزيع لعرض التطورات والابتكارات التكنولوجية المتقدمة في هذا الحدث المرموق.

يتمحور تركيز ميتسومي في معرض جيتكس أفريقيا 2024 حول موضوع “ريادة الحلول المستقبلية اليوم”. وتجسيدًا لهذا الالتزام، ستكشف ميتسومي النقاب عن مجموعة متنوعة من التقنيات الرائدة والحلول المبتكرة التي تعيد تشكيل مشهد تكنولوجيا المعلومات، والاتصالات، والذكاء الاصطناعي، والحلول القائمة على القيمة. وفي مجال الذكاء الاصطناعي، ستعرض ميتسومي التطورات مثل تعلم الآلة، والذكاء الاصطناعي التوليدي، ورؤية الحاسوب، وروبوتات الدردشة التي تعتمد على الذكاء الاصطناعي، وغيرها. وفي قسم عروض القيمة، سيتم التركيز على الحلول السحابية والأمن وحلول البنية التحتية والمزيد. سيكون الخبراء المتمرسون من ميتسومي، جنبًا إلى جنب مع المديرين الرئيسيين، على استعداد لتقديم رؤى وتسهيل المشاركة المباشرة مع أحدث ابتكارات الصناعة. ويضم جناح ميتسومي عمالقة الصناعة من البائعين المرموقين مثل آيسر، وآيري نتوركس، وآسوس، وكانون، وديل تكنولوجيز، وإتش بي إي، وإتش بي، وإنفينيكس، وليكسار، وأوبو، وسامسونج، وسيجيت، وتكنو، وفيفو.

صرح السيد ميتيش شاه، المدير العام لشركة ميتسومي للتوزيع، قائلاً: “يسعدنا أن نعلن عن مشاركتنا في معرض جيتكس أفريقيا 2024”. “في هذا المشهد الابتكاري المتطور باستمرار، يبرز الذكاء الاصطناعي كواحد من أهم المواضيع، ويتوسع باستمرار في نطاقه وتأثيره. ونحن متحمسون لاغتنام هذه الفرصة للكشف عن شراكات وخطط عمل جديدة، وتعزيز التزامنا بقيادة التقدم التكنولوجي، وتمكين الشركات في جميع أنحاء الشرق الأوسط وأفريقيا، وعرض حلولنا من كبار البائعين.

تفضلوا بزيارة ميتسومي للتوزيع في الجناح 5B-20، القاعة رقم 5، السحابة × إنترنت الأشياء × الذكاء الاصطناعي (Stand 5B-20, Hall No.5, CLOUD X IOT X AI)، في الفترة من 29 مايو إلى 31 مايو 2024 للتجربة المباشرة للتقنيات والحلول المتقدمة التي تشكل المستقبل، وللتفاعل مع فريق خبراء ميتسومي، ولاستكشاف أحدث المشاريع والتطورات، ولاكتشاف كيف يمكن لشركة ميتسومي تمكين مؤسستكم من الازدهار في العصر الرقمي.

حول شركة ميتسومي للتوزيع:

ميتسومي للتوزيع هي شركة رائدة في مجال توفير التكنولوجيا المتخصصة في قنوات التوزيع في أفريقيا والشرق الأوسط والدول الأفريقية الناطقة بالفرنسية. رسخت شركة ميتسومي للتوزيع مكانتها بقوة كسلطة موثوقة في المنطقة بفضل ما لديها من أكثر من عقدين من الخبرة. تقدم الشركة مجموعة متنوعة من المنتجات والحلول التقنية المبتكرة، مع التركيز على تكنولوجيا المعلومات والاتصالات والذكاء الاصطناعي والحوسبة السحابية والشبكات والخوادم والتخزين، كما تلتزم شركة ميتسومي للتوزيع بتقديم منتجات فائقة الجودة وخدمة استثنائية وقيمة لا مثيل لها إلى شركائها الكرام. www.mitsumidistribution.com

للاستفسارات الإعلامية، يُرجى التواصل عبر البريد الإلكتروني:

marketing@mitsumidistribution.com

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024

Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter 2024 on Tuesday, May 14, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah’s Q1 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Nyxoah’s Q1 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
IR@nyxoah.com

Attachment

GlobeNewswire Distribution ID 1000950583

FM meets Syrian counterpart on sidelines of Manama summit preparatory meetings


Deputy Prime Minister and Minister of Foreign Affairs and Expatriates, Ayman Safadi, met on Monday with Syrian Minister of Foreign Affairs and Expatriates, Faisal Mekdad, ahead of the Arab Foreign Ministers’ preparatory meeting for the Arab League Council at the summit level, which is hosted by the Kingdom of Bahrain.

The two ministers discussed efforts aimed at halting the Israeli aggression on the Gaza Strip and the humanitarian catastrophe caused by the aggression.

The two ministers also discussed the agenda of the Arab Foreign Ministers’ meeting and ways to enhance coordination and cooperation on priority issues, primarily the Palestinian issue, and the efforts exerted within the Arab context to achieve security and stability in the region.

Safadi and Mekdad touched on efforts to reach a political solution to the Syrian crisis that preserves the unity and cohesion of Syria, realizes the aspirations of its people, respects its sovereignty, rids it of terrorism and provides the necessary conditions for t
he voluntary return of Syrian refugees to their country.

They emphasized the importance of the role of the Arab Ministerial Contact Group on Syria within the efforts made in the context of the Arab track.

Safadi underscored the need to reach a political solution to the Syrian crisis according to a step-by-step methodology in line with UN Security Council Resolution 2254, which addresses all the humanitarian, security and political repercussions of the crisis.

Safadi and Mekdad also covered several bilateral issues, including border security and the fight against drug smuggling, and reviewed the results of the contacts conducted by the concerned authorities in the two countries to stop smuggling operations and defeat the danger they pose.

The two ministers underlined the continuation of consultation and coordination within the framework of the common interest of ending the Syrian crisis and developing cooperation that reflects positively on the two countries.

Source: Jordan News Agency